Immunohistochemical detection of BH3-only proteins in ameloblastic tumors

Oral Diseases

Volumn 14, Issue 6, 2008, Pages 550-555

  Kumamoto, H ^a   Ooya, K ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; Apoptosis; BH3 only protein; Immunohistochemistry

Indexed keywords

ANTIBODY; BH3 PROTEIN; BIM PROTEIN; PROTEIN BAD; PROTEIN BID; PROTEIN NOXA; PUMA PROTEIN;

AMELOBLASTOMA; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CELL DEATH; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYTOPLASM; EPITHELIUM CELL; GRANULAR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TOOTH FLORA; TUMOR CELL;

AMELOBLASTOMA; APOPTOSIS REGULATORY PROTEINS; BASEMENT MEMBRANE; BCL-ASSOCIATED DEATH PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL DIFFERENTIATION; DENTAL ENAMEL; DENTAL SAC; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MEMBRANE PROTEINS; MESODERM; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TOOTH GERM;

EID: 49749126778     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01417.x     Document Type: Article

References (35)

1. Adams JM, Cory S (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281 : 1322 1326.
2. Bouillet P, Metcalf D, Huang DC et al (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 : 1735 1938.
3. Bouillet P, Cory S, Zhang LC et al (2001). Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 1 : 645 653.
4. Heikinheimo K, Jee KJ, Niini T et al (2002). Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 81 : 525 530.
5. Hengartner MO (2000). The biochemistry of apoptosis. Nature 407 : 770 776.
6. Hershko T, Ginsberg D (2004). Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279 : 8627 8634.
7. Hoque MO, Begum S, Sommer M et al (2003). PUMA in head and neck cancer. Cancer Lett 199 : 75 81.
8. Jansson AK, Emterling AM, Arbman G et al (2003). Noxa in colorectal cancer: a study on DNA, mRNA and protein expression. Oncogene 22 : 4675 4678.
9. Johnstone RW, Ruefli AA, Lowe SW (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108 : 153 164.
10. Karst AM, Dai DL, Martinka M et al (2005). PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 24 : 1111 1116.
11. Kerr JF, Wyllie AH, Currie AR (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 : 239 257.
12. Kindaichi K (1980). An electron microscopic study of cell death in molar tooth germ epithelia of mouse embryos. Arch Histol Jpn 43 : 289 304.
13. Kumamoto H (1997). Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 26 : 419 425.
14. Kumamoto H (2006). Molecular pathology of odontogenic tumors. J Oral Pathol Med 35 : 65 74.
15. Kumamoto H, Ooya K (1999). Immunohistochemical analysis of bcl-2 family proteins in benign and malignant ameloblastomas. J Oral Pathol Med 28 : 343 349.
16. Kumamoto H, Ooya K (2004). Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas. Virchows Arch 444 : 164 170.
17. Kumamoto H, Ooya K (2005a). Expression of tumor necrosis factor α, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pathol Med 34 : 287 294.
18. Kumamoto H, Ooya K (2005b). Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas. J Oral Pathol Med 34 : 565 572.
19. Kumamoto H, Ooya K (2006). Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas. J Oral Pathol Med 35 : 183 189.
20. Kumamoto H, Ooya K (2007). Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors. Oral Dis 13 : 461 467.
21. Kumamoto H, Kimi K, Ooya K (2001a). Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 30 : 309 315.
22. Kumamoto H, Kimi K, Ooya K (2001b). Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 30 : 596 602.
23. Philipsen HP, Reichart PA, Slootweg PJ et al (2005). Odontogenic tumours. In : Barnes L, Eveson JW, Reichart PA, Sidransky D, eds WHO classification head and neck tumours. IARC Press : Lyon, pp. 283 327.
24. Ranger AM, Zha J, Harada H et al (2003). Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100 : 9324 9329.
25. Sandra F, Nakamura N, Mitsuyasu T et al (2001). Two relatively distinct patterns of ameloblastoma: an anti- apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre). Histopathology 39 : 93 98.
26. Sciubba JJ, Fantasia JE, Kahn LB (2001). Tumors and cysts of the jaw. Armed Forces Institute of Pathology : Washington, DC, pp. 71 99.
27. Shibue T, Taniguchi T (2006). BH3-only proteins: integrated control point of apoptosis. Int J Cancer 119 : 2036 2043.
28. Slootweg PJ (1995). p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 24 : 393 397.
29. Slootweg PJ, de Weger RA (1994). Immunohistochemical demonstration of bcl-2 protein in human tooth germs. Arch Oral Biol 39 : 545 550.
30. Tagawa H, Karnan S, Suzuki R et al (2005). Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24 : 1348 1358.
31. Vaahtokari A, Aberg T, Thesleff I (1996). Apoptosis in the developing tooth: association with an embryonic signaling center and suppression by EGF and FGF-4. Development 122 : 121 129.
32. Vaux DL, Korsmeyer SJ (1999). Cell death in development. Cell 96 : 245 254.
33. Vousden KH, Lu X (2002). Live or let die: the cell's response to p53. Nat Rev Cancer 2 : 594 604.
34. Yin XM, Wang K, Gross A et al (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400 : 886 891.
35. Zinkel SS, Ong CC, Ferguson DO et al (2003). Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev 17 : 229 239.